Skip to content

Drug interactions

Baricitinib + Trastuzumab

Severity: Moderate

Baricitinib and Trastuzumab: moderate interaction.

Last updated

For healthcare professionals — reference only. This page is a brief summary, not medical advice and not a substitute for official labeling or clinical judgement. Always verify before prescribing or dispensing.

Summary

Baricitinib is immunosuppressive and trastuzumab is usually given with myelosuppressive chemotherapy, so infection risk may rise. Trastuzumab alone has limited immunosuppressive activity.

What this interaction means in plain words

Baricitinib and Trastuzumab can affect each other. The combination is often manageable, but it may need a change of dose, a change of timing, or extra checks while both are taken.

Baricitinib belongs to Musculoskeletal; Trastuzumab belongs to Oncology.

Evidence level: Low

Why it happens

Additive immunosuppressive and hematologic effects; no pharmacokinetic interaction is established.

What to do

Monitor neutrophil and lymphocyte counts and for infection. Reassess the need for baricitinib during cancer treatment.

What to ask your pharmacist

  • Should I take them at different times of day?
  • Does the dose of either medicine need to change?
  • Is there anything I should avoid, such as alcohol or certain foods, while on both?

Bring a full list of your medicines, including over-the-counter products, supplements and herbal remedies, to every pharmacy visit.

Pro+ members

Unlock the full page

Create an account and start a Pro+ trial to unlock the full management advice for Baricitinib and Trastuzumab, the additional notes, the evidence detail and the whole-prescription interaction checker.

  • Full clinical management advice
  • Additional notes
  • Evidence detail
  • Interaction checker for a whole prescription

Try Pro+ free for 14 days on the web. No card needed.

Frequently asked questions

Can I take Baricitinib with Trastuzumab?

MediHelp rates the interaction as moderate. Baricitinib and Trastuzumab can affect each other. The combination is often manageable, but it may need a change of dose, a change of timing, or extra checks while both are taken. Baricitinib is immunosuppressive and trastuzumab is usually given with myelosuppressive chemotherapy, so infection risk may rise. Trastuzumab alone has limited immunosuppressive activity.

How serious is the interaction between Baricitinib and Trastuzumab?

MediHelp rates it moderate, on a four-level scale (minor, moderate, major, contraindicated) based on published labels and references. What to do, in brief: Monitor neutrophil and lymphocyte counts and for infection. Reassess the need for baricitinib during cancer treatment.

What other medicines interact with Baricitinib?

MediHelp also lists interactions of Baricitinib with, for example, Adenovirus types 4 and 7 live, Bcg vaccine live, Tofacitinib. The full list is on the Baricitinib page.

Full monographs, dosing and an interaction checker in the MediHelp app

Open the complete reference, check multi-drug interactions and use dosing tools in the MediHelp app.

Browse A–Z · Drug interactions

Get the app Sign in